• $.$$


Prosnack Natural Foods operates a Safe Quality Food (SQF) certified food manufacturing facility. In addition to being certified SQF, we are also HACCP and cGMP certified.

These certifications are validation that our standard operating procedures (SOPs) are of the highest integrity. Many retailers demand that products offered for sale in their stores be made in highly certified facilities such as ours.

Prosnack can take your existing recipe/formulation and produce it in our modern facility. We also have hundreds of formulations that can form the basis to your next product launch.

Our facility is capable of producing raw, nutritious bars & bites… mostly from plant-based ingredients. We can produce 40,000 bars and 100,000 bites per 8 hour shift.


Prosnack’s R&D department is capable of creating custom formulated bars & bites to meet contract manufacturing objectives. Much work needs to be done when considering new products including nutritional goals, price points, mouth feel…and of course TASTE!

We can scale up a ‘family favourite recipe’ accommodating for larger runs of product or even take your existing recipe and modifying it to meet your expectations.


Naturally Splendid has an internal graphic department that will take your design ideas and create commercial ready, effective branding, packaging and marketing materials.


Naturally Splendid is building an expanding portfolio of proprietary intellectual property focused on the numerous uses of plant-based ingredients in a broad spectrum of applications.

The Company is developing, producing and commercializing a new generation of plant-derived, bio-active ingredients, nutrient dense foods, and related products.

HempOmega™ – micro-encapsulated hemp oil for use in foods, topicals and sports nutrition

Hemp Protein Isolate – 80%+ concentration is greater than most every other hemp protein. For use as an ingredient in daily food items as well as for an advanced sports line of products.

Cavaltinib™ – a patented curcumin extract that is being prepared for a Health Canada phase 2 clinical trial for the effectiveness to treat COVID-19. In addition to pursing a COVID-19 treatment, there is optimism that ensuing research will help expand the indications for Cavaltinib™ to respiratory conditions such as asthma and COPD; and reveal mechanisms of activity in cases of autoimmune diseases like colitis, crohn’s and rheumatoid arthritis.

This website collects data via Google Analytics. Click here to opt in. Click here to opt out.